192 related articles for article (PubMed ID: 22957431)
1. Preparation and characterization of polymeric nanoparticles for siRNA delivery to down-regulate the expressions of exogenous and endogenous target genes.
Huang W; Lv M; Gao ZG; Jin MJ; Xu YJ; Yu XD; Jin ZH; Yin XZ
Pharmazie; 2012 Aug; 67(8):676-80. PubMed ID: 22957431
[TBL] [Abstract][Full Text] [Related]
2. [Small interfering RNA delivery mediated by mPEG-PCL-g-PEI polymer nanoparticles].
Huang W; Lü M; Gao ZG; Jin MJ; Yang CQ
Yao Xue Xue Bao; 2011 Mar; 46(3):344-9. PubMed ID: 21626792
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles.
Yang F; Huang W; Li Y; Liu S; Jin M; Wang Y; Jia L; Gao Z
Biomaterials; 2013 Jul; 34(22):5689-99. PubMed ID: 23632321
[TBL] [Abstract][Full Text] [Related]
4. Nanoformulation of siRNA silencing Bcl-2 gene and its implication in cancer therapy.
Jagani HV; Josyula VR; Hariharapura RC; Palanimuthu VR; Gang SS
Arzneimittelforschung; 2011; 61(10):577-86. PubMed ID: 22164966
[TBL] [Abstract][Full Text] [Related]
5. Targeted decationized polyplexes for siRNA delivery.
Novo L; Takeda KM; Petteta T; Dakwar GR; van den Dikkenberg JB; Remaut K; Braeckmans K; van Nostrum CF; Mastrobattista E; Hennink WE
Mol Pharm; 2015 Jan; 12(1):150-61. PubMed ID: 25384057
[TBL] [Abstract][Full Text] [Related]
6. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
[TBL] [Abstract][Full Text] [Related]
7. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.
Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C
Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280
[TBL] [Abstract][Full Text] [Related]
8. Gold nanostar-polymer hybrids for siRNA delivery: Polymer design towards colloidal stability and in vitro studies on breast cancer cells.
Sardo C; Bassi B; Craparo EF; Scialabba C; Cabrini E; Dacarro G; D'Agostino A; Taglietti A; Giammona G; Pallavicini P; Cavallaro G
Int J Pharm; 2017 Mar; 519(1-2):113-124. PubMed ID: 28093325
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization and transfection efficiency of cationic PEGylated PLA nanoparticles as gene delivery systems.
Chen J; Tian B; Yin X; Zhang Y; Hu D; Hu Z; Liu M; Pan Y; Zhao J; Li H; Hou C; Wang J; Zhang Y
J Biotechnol; 2007 Jun; 130(2):107-13. PubMed ID: 17467097
[TBL] [Abstract][Full Text] [Related]
10. N-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver.
Wang HX; Xiong MH; Wang YC; Zhu J; Wang J
J Control Release; 2013 Mar; 166(2):106-14. PubMed ID: 23266452
[TBL] [Abstract][Full Text] [Related]
11. Monodispersed brush-like conjugated polyelectrolyte nanoparticles with efficient and visualized siRNA delivery for gene silencing.
Jiang R; Lu X; Yang M; Deng W; Fan Q; Huang W
Biomacromolecules; 2013 Oct; 14(10):3643-52. PubMed ID: 24040909
[TBL] [Abstract][Full Text] [Related]
12. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
Liu P; Yu H; Sun Y; Zhu M; Duan Y
Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
[TBL] [Abstract][Full Text] [Related]
13. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.
Yang XZ; Dou S; Sun TM; Mao CQ; Wang HX; Wang J
J Control Release; 2011 Dec; 156(2):203-11. PubMed ID: 21839126
[TBL] [Abstract][Full Text] [Related]
14. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
[TBL] [Abstract][Full Text] [Related]
15. Polymer-related off-target effects in non-viral siRNA delivery.
Merkel OM; Beyerle A; Beckmann BM; Zheng M; Hartmann RK; Stöger T; Kissel TH
Biomaterials; 2011 Mar; 32(9):2388-98. PubMed ID: 21183213
[TBL] [Abstract][Full Text] [Related]
16. Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells.
Darvishi MH; Nomani A; Amini M; Shokrgozar MA; Dinarvand R
Int J Pharm; 2013 Nov; 456(2):408-16. PubMed ID: 24012865
[TBL] [Abstract][Full Text] [Related]
17. Peptide-like Polymers Exerting Effective Glioma-Targeted siRNA Delivery and Release for Therapeutic Application.
An S; He D; Wagner E; Jiang C
Small; 2015 Oct; 11(38):5142-50. PubMed ID: 26222334
[TBL] [Abstract][Full Text] [Related]
18. Chitosan nanoparticles for siRNA delivery: optimizing formulation to increase stability and efficiency.
Ragelle H; Riva R; Vandermeulen G; Naeye B; Pourcelle V; Le Duff CS; D'Haese C; Nysten B; Braeckmans K; De Smedt SC; Jérôme C; Préat V
J Control Release; 2014 Feb; 176():54-63. PubMed ID: 24389132
[TBL] [Abstract][Full Text] [Related]
19. Layer-by-layer nanoparticles as an efficient siRNA delivery vehicle for SPARC silencing.
Tan YF; Mundargi RC; Chen MH; Lessig J; Neu B; Venkatraman SS; Wong TT
Small; 2014 May; 10(9):1790-8. PubMed ID: 24510544
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional triblock co-polymer mP3/4HB-b-PEG-b-lPEI for efficient intracellular siRNA delivery and gene silencing.
Zhou L; Chen Z; Wang F; Yang X; Zhang B
Acta Biomater; 2013 Apr; 9(4):6019-31. PubMed ID: 23295402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]